Advertisement

Infiltration of Host Cells in Local Tumor Sites Triggered by the Administration of Anti-Tumor Polysaccharide, Lentinan

  • T. Suga
  • M. Izawa
  • A. Yamashita
  • G. Chihara

Abstract

Lentinan (LNT), a ß-(1→3)-D-glucan type polysaccharide with ß-(1→6)-branched chain, exerts antitumor activities for animal models and clinical use (Chihara et al. 1970, Zakany et al. 1980, Suga et al. 1984, Chihara et al. 1987, Taguchi et al. 1985). A number of previous studies has revealed that the antitumor action of lentinan is exerted through the activation of host immune systems, particularly activation of T-cell macrophage synergism system(Maeda and Chihara 1973, Dennert and Tacker 1973, Hamuro and Chihara 1985). In the present study, we report that tumor growth inhibitory activity of LNT varies depending on the difference of tumor-host systems. The difference of sensitivity for LNT among various tumor strains was investigated from a view point of both histological changes of tumors and biological activities of tumor infiltrated cells which were induced with LNT treatment.

Keywords

Antitumor Activity Histological Change Single Cell Suspension Tumor Inoculation Tumor Suppressive Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chihara G, Hamuro J, Maeda YY, Arai Y, Fukuoka F (1970) Fractionation and purification of the polysaccharides with marked antitumor activity, especially, from Lentinus edodes ( Berk.) Sing., an edible mushroom. Cancer Res 30: 2776PubMedGoogle Scholar
  2. Zakany J, Chihara G, Fachet J (1980) Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts. Int J Cancer 25: 371PubMedCrossRefGoogle Scholar
  3. Suga T, Shiio T, Maeda YY, Chihara G (1984) Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene induced carcinogenesis. Cancer Res 44: 5132PubMedGoogle Scholar
  4. Chihara G,Suga T, Hamuro J (1987) Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulater: an overview. Cancer Detect. Prevent Suppl 1: 423Google Scholar
  5. Taguchi T, Furue H, Kimura T, et al. (1985) End-point of Phase III study of lentinan. Gan to Kagakuryouhou [Jpn Cancer Chemother] 12: 366Google Scholar
  6. Maeda YY, Chihara G (1973) The effect of neonatal thymectomy on the antitumor activity of lentinan, carboxymethylpachymaran andymosan, and their effects on various immune responses. Int J Cancer 11: 153PubMedCrossRefGoogle Scholar
  7. Dennert G, Tacker D (1973) Antitumor polysaccharide lentina rA T-cell adjuvant. JNCI 51: 1727PubMedGoogle Scholar
  8. Hamuro J, Chihara G (1985) Lentinan, a T-cell oriented immunopotentiator: Its experimental and clinical applications and possible mechanism of immune modulation. In Fenichel RL, Chirigos MA, eds: Immune modulation agents and their mechanisms. MarcelDekker, New York, p 409Google Scholar
  9. Tokuzen R (1971) Comparison of local cellular reaction of tumor grafts in mice treated with some plant polysaccharides. Cancer Res. 31: 1590PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • T. Suga
    • 1
  • M. Izawa
    • 1
  • A. Yamashita
    • 2
  • G. Chihara
    • 3
  1. 1.Central Research LaboratoriesAjinomoto Company IncorporationTotsuka-ku, Yokohama 244Japan
  2. 2.Hamamatsu University School of MedicineHamamatsu 431-31Japan
  3. 3.Biotechnology Research CenterTeikyo UniversityFutako, Takatsu-ku Kawasaki 213Japan

Personalised recommendations